We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
Takeda Pharmaceuticals Australia has notified us that the shortage of Vyvanse 60 mg capsules will be extended until 30 April 2024. The shortage of Vyvanse 40 mg is also expected to resolve on 30 April 2024.
The shortages of Vyvanse 30 mg and 50 mg have resolved and supply has returned to normal.
The most up-to-date information about these shortages is published on the Medicine Shortage Reports Database.
Important information for patients, carers, pharmacists and prescribers is available at About the shortage of Vyvanse (lisdexamfetamine dimesilate) capsules.